News Sentiment

REGN sentiment intelligence

Regeneron Pharmaceuticals, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 22 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 578.90 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.2% over one week, +9.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Regeneron (REGN) Stock Looks Discounted As It Holds A 24% Gain

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 1.2% Price digesting
Trend fit Trend inactive 9.5% over four weeks
Fair value -17.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 11
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
simplywall.st 4
marketscreener.com 3
GuruFocus 1
Stocktwits 1
Trefis 1
Stock Titan 1
Traders Union 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 3
Analyst action 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-22 of 22